Endo Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference

Tuesday, May 10, 2011 Press Release
Email Print This Page Comment

CHADDS FORD, Pa., May 9, 2011 -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Bank of

America Merrill Lynch Healthcare Conference on Thursday, May 12, 2011 at 11:50 a.m. PT.  Alan Levin executive vice president and chief financial officer will review the company's products and
development programs.

The presentation will be webcast live and can be accessed from Endo's website at http://www.endo.com/ under the investors section.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit www.endo.com/.

SOURCE Endo Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook